SCHEMBL6174589

SCHEMBL6174589

CNC(=O)c1cnccc1CC1(C)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.42
GAA P10253 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ALDH1A1 P00352 1/20 0.42
ICAM1 P05362 1/20 0.36
SELE P16581 1/20 0.36
VCAM1 P19320 1/20 0.36
SCN2A Q99250 2/20 0.36
SCN10A Q9Y5Y9 2/20 0.36
EGLN1 Q9GZT9 1/20 0.36
FLT1 P17948 2/20 0.35
KDR P35968 2/20 0.35
SCN9A Q15858 3/20 0.35
AR P10275 1/20 0.35
TRPV1 Q8NER1 2/20 0.35
NAMPT P43490 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
POLB P06746 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170496 0.90 CYP3A4 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6176355 0.89 CYP3A4 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173171 0.89 KDR (0.42) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174456 0.88 MAPT (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6176618 0.86 SCN2A (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173349 0.86 ALDH1A1 (0.39) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173183 0.85 CYP3A4 (0.39) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173046 0.84 CYP3A4 (0.37) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6171757 0.84 CYP3A4 (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6175575 0.84 EPHX2 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed